Pharmacogenomics

Primum non nocere: adverse drug events must be taken seriously
pp. 311-314(4)
Authors: Gurwitz, David; McLeod, Howard L

It''s ALL in the genes
pp. 315-317(3)

Circulating VEGF reduction, response and outcome in advanced colorectal cancer patients treated with cetuximab plus irinotecan
pp. 319-327(9)
Authors: Vincenzi, Bruno; Santini, Daniele; Russo, Antonio; Gavasci, Michele; Battistoni, Fabrizio; Dicuonzo, Giordano; Rocci, Laura; Rosaria, Valerio Maria; Gebbia, Nicola; Tonini, Giuseppe

Factors affecting the interindividual variability of warfarin dose requirement in adult Korean patients
pp. 329-337(9)
Authors: Cho, Hyun-Jung; Sohn, Kie-Ho; Park, Hyang-Mi; Lee, Kyung-Hoon; Choi, BoYoung; Kim, Seonwoo; Kim, June-Soo; On, Young-Keun; Chun, Mi-Ryung; Kim, Hee-Jin; Kim, Jong-Won; Lee, Soo-Youn

Polymorphisms in the CYP19 gene that influence bone mineral density
pp. 339-352(14)
Authors: Riancho, Joséé A

Analytical validation of genotyping assays in the biomarker laboratory
pp. 353-368(16)
Authors: Isler, Jennifer A; Vesterqvist, Ole E; Burczynski, Michael E

Nutrigenomics: concepts and applications to pharmacogenomics and clinical medicine
pp. 369-390(22)
Authors: Kaput, Jim; Perlina, Alla; Hatipoglu, Betul; Bartholomew, Amelia; Nikolsky, Yuri

Human rights and ethics in genomic research: rethinking the model
pp. 391-395(5)
Author: Ashcroft, Richard E

Genomic Health, Inc.
pp. 397-399(3)
Author: Baker, J

Iconix Biosciences, Inc.
pp. 401-405(5)
Authors: Fielden, Mark R; Halbert, Donald N

Obituary: Kenneth Anthony Kalanyi Kebba (Tony Kebba)
pp. 407-408(2)

Recent HIV-1 infection in a high-risk Ugandan cohort: implications for Phase IIB test-of-concept HIV vaccine trials
pp. 409-414(6)
Authors: Kebba, Anthony; Imami, Nesrina; Bugembe-Lule, Daniel; Senkaali, David; Kaleebu, Pontiano; Grosskurth, Heiner; Gotch, Frances